{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:03:31Z","timestamp":1791597811293,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lyme borreliosis (LB), caused by <jats:italic>Borrelia burgdorferi <\/jats:italic>sensu lato (Bbsl), is the most common tick-borne disease in Europe. Although public health surveillance for LB has been conducted in Romania since 2007, the extent of under-detection of Bbsl infections by LB surveillance has not been estimated. We therefore estimated the under-detection of symptomatic Bbsl infections by LB surveillance to better understand the LB burden in Romania.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The number of incident symptomatic Bbsl infections were estimated from a seroprevalence study conducted in six counties (population 2.3\u00a0M) and estimates of the symptomatic proportion and duration of persistence of anti-Bbsl immunoglobulin G (IgG) antibodies. The number of incident symptomatic Bbsl infections were compared with the number of surveillance-reported LB cases to derive an under-detection multiplier, and then the under-detection multiplier was applied to LB surveillance data to estimate the incidence of symptomatic Bbsl infection from 2018\u2009to\u20092023.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We estimate that there were 1968 individuals with incident symptomatic Bbsl infection in the six counties where the seroprevalence study was conducted in 2020, compared with the 187 surveillance-reported LB cases, resulting in an under-detection multiplier of 10.5 (i.e., for every surveillance-reported LB case, there were 10.5 symptomatic incident Bbsl infections). The incidence of symptomatic Bbsl infection in the six counties was 86.9\/100,000 population in 2023, similar to the incidence in 2018\u22122020 (86.0) and higher than in 2021\u22122022 (40.3).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There is a higher incidence of symptomatic Bbsl infection than is reported through public health surveillance for LB in Romania. Additional efforts are needed to strengthen disease prevention and address the important public health problem of LB.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphic Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-024-06449-5","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T13:02:33Z","timestamp":1725541353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Incidence of symptomatic Borrelia burgdorferi sensu lato infection in Romania, 2018\u22122023"],"prefix":"10.1186","volume":"17","author":[{"given":"Frederick J.","family":"Angulo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Purdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Lup\u0219e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Hristea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Briciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Colby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Halsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Brestrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Mo\u00efsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"6449_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","volume":"379","author":"G Stanek","year":"2012","unstructured":"Stanek G, Wormser G, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379:461\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(11)60103-7.","journal-title":"Lancet"},{"key":"6449_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1089\/vbz.2022.0071","volume":"23","author":"L Burn","year":"2023","unstructured":"Burn L, Tran TMP, Pilz A, Vyse A, Fletcher MA, Angulo FJ, et al. Incidence of Lyme Borreliosis in Europe from National Surveillance systems (2005\u20132020). Vector Borne Zoonotic Dis Larchmt N. 2023;23:156\u201371. https:\/\/doi.org\/10.1089\/vbz.2022.0071.","journal-title":"Vector Borne Zoonotic Dis Larchmt N"},{"key":"6449_CR3","doi-asserted-by":"publisher","first-page":"30569","DOI":"10.2807\/1560-7917.ES.2017.22.27.30569","volume":"22","author":"CC van den Wijngaard","year":"2017","unstructured":"van den Wijngaard CC, Hofhuis A, Sim\u00f5es M, Rood E, van Pelt W, Zeller H, et al. Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area. Euro Surveill. 2017;22:30569. https:\/\/doi.org\/10.2807\/1560-7917.ES.2017.22.27.30569.","journal-title":"Euro Surveill"},{"key":"6449_CR4","unstructured":"Centrul Na\u021bional de Supraveghere \u015fi Control al Bolilor Transmisibile-Boala Lyme. Available online: http:\/\/www.cnscbt.ro\/index.php\/analiza-date-supraveghere\/boala-lyme-1?limit=10&limitstart=0. Accessed 1 May 2024."},{"key":"6449_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1471-2458-14-147","volume":"14","author":"CL Gibbons","year":"2014","unstructured":"Gibbons CL, Mangen MJJ, Plass D, Havelaar AH, Brooke RJ, Kramarz P, et al. Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BMC Public Health. 2014;14:147. https:\/\/doi.org\/10.1186\/1471-2458-14-147.","journal-title":"BMC Public Health"},{"key":"6449_CR6","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3201\/eid1512.091413","volume":"15","author":"C Reed","year":"2009","unstructured":"Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis. 2009;15:2004\u20137. https:\/\/doi.org\/10.3201\/eid1512.091413.","journal-title":"Emerg Infect Dis"},{"key":"6449_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3201\/eid1701.p11101","volume":"17","author":"E Scallan","year":"2011","unstructured":"Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, et al. Foodborne illness acquired in the United States\u2014major pathogens. Emerg Infect Dis. 2011;17:7\u201315. https:\/\/doi.org\/10.3201\/eid1701.p11101.","journal-title":"Emerg Infect Dis"},{"key":"6449_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.33706","volume":"4","author":"FJ Angulo","year":"2021","unstructured":"Angulo FJ, Finelli L, Swerdlow DL. Estimation of US SARS-CoV-2 Infections, symptomatic infections, hospitalizations, and deaths using seroprevalence surveys. JAMA Netw Open. 2021;4:e2033706. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.33706.","journal-title":"JAMA Netw Open"},{"key":"6449_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2478\/rrlm-2014-0020","volume":"1","author":"B Tilea","year":"2014","unstructured":"Tilea B, Tripon G, Septimiu V, Tilea I. Serological, clinical and epidemiological aspects of Lyme borreliosis in Mures County, Romania. Rom Rev Lab Med. 2014;1:22. https:\/\/doi.org\/10.2478\/rrlm-2014-0020.","journal-title":"Rom Rev Lab Med"},{"key":"6449_CR10","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/microorganisms10071392","volume":"10","author":"V Briciu","year":"2022","unstructured":"Briciu V, Flonta M, Leucu\u021ba D, Lup\u0219e M. The diagnostic challenges and clinical and serological outcome in patients hospitalized for suspected lyme neuroborreliosis. Microorganisms. 2022;10:1392. https:\/\/doi.org\/10.3390\/microorganisms10071392.","journal-title":"Microorganisms"},{"key":"6449_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/vbz.2022.0069","volume":"23","author":"L Burn","year":"2023","unstructured":"Burn L, Pilz A, Vyse A, Guti\u00e9rrez Rab\u00e1 AV, Angulo FJ, Tran TMP, et al. Seroprevalence of Lyme Borreliosis in Europe: results from a systematic literature review (2005\u20132020). Vector Borne Zoonotic Dis. 2023;23:195\u2013220. https:\/\/doi.org\/10.1089\/vbz.2022.0069.","journal-title":"Vector Borne Zoonotic Dis"},{"key":"6449_CR12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/s13071-021-05099-1","volume":"14","author":"Z Kalm\u00e1r","year":"2021","unstructured":"Kalm\u00e1r Z, Briciu V, Coroian M, Flonta M, R\u0103dulescu AL, Topan A, et al. Seroprevalence of antibodies against Borrelia burgdorferi sensu lato in healthy blood donors in Romania: an update. Parasit Vectors. 2021;14:596. https:\/\/doi.org\/10.1186\/s13071-021-05099-1.","journal-title":"Parasit Vectors"},{"key":"6449_CR13","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1016\/j.ijid.2010.10.006","volume":"15","author":"L Fryland","year":"2011","unstructured":"Fryland L, Wilhelmsson P, Lindgren PE, Nyman D, Ekerfelt C, Forsberg P. Low risk of developing Borrelia burgdorferi infection in the south-east of Sweden after being bitten by a Borrelia burgdorferi-infected tick. Int J Infect Dis. 2011;15:e174\u201381. https:\/\/doi.org\/10.1016\/j.ijid.2010.10.006.","journal-title":"Int J Infect Dis"},{"key":"6449_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ttbdis.2015.08.009","volume":"7","author":"P Wilhelmsson","year":"2016","unstructured":"Wilhelmsson P, Fryland L, Lindblom P, et al. A prospective study on the incidence of Borrelia burgdorferi sensu lato infection after a tick bite in Sweden and on the \u00c5land Islands, Finland (2008\u20132009). Ticks Tick Borne Dis. 2016;7:71\u20139. https:\/\/doi.org\/10.1016\/j.ttbdis.2015.08.009.","journal-title":"Ticks Tick Borne Dis"},{"key":"6449_CR15","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3201\/eid2704.203366","volume":"27","author":"M Markowicz","year":"2021","unstructured":"Markowicz M, Sch\u00f6tta AM, H\u00f6ss D, et al. Infections with tickborne pathogens after tick bite, Austria, 2015\u20132018. Emerg Infect Dis. 2021;27:1048\u201356. https:\/\/doi.org\/10.3201\/eid2704.203366.","journal-title":"Emerg Infect Dis"},{"key":"6449_CR16","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3390\/microorganisms11051100","volume":"11","author":"N Carlstr\u00f6mer Berth\u00e9n","year":"2023","unstructured":"Carlstr\u00f6mer Berth\u00e9n N, Tompa E, Olausson S, et al. The AxBioTick Study: Borrelia species and tick-borne encephalitis virus in ticks, and clinical responses in tick-bitten individuals on the Aland Islands, Finland. Microorganisms. 2023;11:1100. https:\/\/doi.org\/10.3390\/microorganisms11051100.","journal-title":"Microorganisms"},{"key":"6449_CR17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ttbdis.2014.04.009","volume":"5","author":"MK Faulde","year":"2014","unstructured":"Faulde MK, Rutenfranz M, Hepke J, Rogge M, G\u00f6rner A, Keth A. Human tick infestation pattern, tick-bite rate, and associated Borrelia burgdorferi s.l. infection risk during occupational tick exposure at the Seedorf military training area northwestern Germany. Ticks Tick Borne Dis. 2014;5:594\u20139. https:\/\/doi.org\/10.1016\/j.ttbdis.2014.04.009.","journal-title":"Ticks Tick Borne Dis."},{"key":"6449_CR18","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/jcm.32.6.1519-1525.1994","volume":"32","author":"S Hammers-Berggren","year":"1994","unstructured":"Hammers-Berggren S, Lebech AM, Karlsson M, Svenungsson B, Hansen K, Stiernstedt G. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. J Clin Microbiol. 1994;32:1519\u201325. https:\/\/doi.org\/10.1128\/jcm.32.6.1519-1525.1994.","journal-title":"J Clin Microbiol"},{"key":"6449_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3109\/00365549409011804","volume":"26","author":"S Hammers-Berggren","year":"1994","unstructured":"Hammers-Berggren S, Lebech AM, Karlsson M, Andersson U, Hansen K, Stiernstedt G. Serological follow-up after treatment of Borrelia arthritis and acrodermatitis chronica atrophicans. Scand J Infect Dis. 1994;26:339\u201347. https:\/\/doi.org\/10.3109\/00365549409011804.","journal-title":"Scand J Infect Dis"},{"key":"6449_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/000155500459312","volume":"80","author":"H Lomholt","year":"2000","unstructured":"Lomholt H, Lebech AM, Hansen K, Brandrup F, Halkier-S\u00f8rensen L. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans. Acta Derm Venereol. 2000;80:362\u20136. https:\/\/doi.org\/10.1080\/000155500459312.","journal-title":"Acta Derm Venereol"},{"key":"6449_CR21","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/archderm.142.7.862","volume":"142","author":"M Glatz","year":"2006","unstructured":"Glatz M, Golestani M, Kerl H, M\u00fcllegger RR. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients. Arch Dermatol. 2006;142:862\u20138. https:\/\/doi.org\/10.1001\/archderm.142.7.862.","journal-title":"Arch Dermatol"},{"key":"6449_CR22","doi-asserted-by":"publisher","first-page":"1500.e1","DOI":"10.1016\/j.cmi.2022.06.001","volume":"28","author":"MM Tetens","year":"2022","unstructured":"Tetens MM, Dessau R, Ellermann-Eriksen S, et al. The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study. Clin Microbiol Infect. 2022;28:1500.e1-1500.e6. https:\/\/doi.org\/10.1016\/j.cmi.2022.06.001.","journal-title":"Clin Microbiol Infect"},{"key":"6449_CR23","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.cmi.2023.09.017","volume":"29","author":"M Westerholt","year":"2023","unstructured":"Westerholt M, Krogfelt KA, Dessau RB, Ocias LF. Exploring the dynamics of Borrelia burgdorferi sensu lato antibodies\u2014a registry-based study on laboratory data from Sweden and Denmark. Clin Microbiol Infect. 2023;29:1561\u20136. https:\/\/doi.org\/10.1016\/j.cmi.2023.09.017.","journal-title":"Clin Microbiol Infect"},{"key":"6449_CR24","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3390\/microorganisms8121859","volume":"8","author":"T Woudenberg","year":"2020","unstructured":"Woudenberg T, B\u00f6hm S, B\u00f6hmer M, et al. Dynamics of Borrelia burgdorferi-specific antibodies: seroconversion and seroreversion between two population-based, cross-sectional surveys among adults in Germany. Microorganisms. 2020;8:1859. https:\/\/doi.org\/10.3390\/microorganisms8121859.","journal-title":"Microorganisms."},{"key":"6449_CR25","doi-asserted-by":"publisher","first-page":"2200855","DOI":"10.2807\/1560-7917.ES.2023.28.34.2200855","volume":"28","author":"S B\u00f6hm","year":"2023","unstructured":"B\u00f6hm S, Woudenberg T, Stark K, et al. Seroprevalence, seroconversion and seroreversion of Borrelia burgdorferi-specific IgG antibodies in two population-based studies in children and adolescents, Germany, 2003 to 2006 and 2014 to 2017. Euro Surveill. 2023;28:2200855. https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.34.2200855.","journal-title":"Euro Surveill"},{"key":"6449_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/vbz.2022.0051","volume":"23","author":"J Olsen","year":"2023","unstructured":"Olsen J, Angulo FJ, Pilz A, Halsby K, Kelly P, Turunen J, et al. Estimated number of symptomatic Lyme Borreliosis cases in adults in Finland in 2021 using seroprevalence data to adjust the number of surveillance-reported cases: a general framework for accounting for underascertainment by public health surveillance. Vector Borne Zoonotic Dis Larchmt N. 2023;23:265\u201372. https:\/\/doi.org\/10.1089\/vbz.2022.0051.","journal-title":"Vector Borne Zoonotic Dis Larchmt N"},{"key":"6449_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.puhe.2023.03.002","volume":"17","author":"J Olsen","year":"2023","unstructured":"Olsen J, Angulo FJ, Pilz A, Halsby K, Kelly P, Brestrich G, et al. Estimated number of symptomatic Lyme borreliosis cases in Germany in 2021 after adjusting for under-ascertainment. Public Health. 2023;17:1\u20139. https:\/\/doi.org\/10.1016\/j.puhe.2023.03.002.","journal-title":"Public Health"},{"key":"6449_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041321","volume":"7","author":"M Dehnert","year":"2012","unstructured":"Dehnert M, Fingerle V, Klier C, Talaska T, Schlaud M, Krause G, et al. Seropositivity of Lyme Borreliosis and associated risk factors: a population-based study in children and adolescents in Germany (KiGGS). PLoS ONE. 2012;7:e41321. https:\/\/doi.org\/10.1371\/journal.pone.0041321.","journal-title":"PLoS ONE"},{"key":"6449_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3201\/eid2101.140009","volume":"21","author":"H Wilking","year":"2015","unstructured":"Wilking H, Fingerle V, Klier C, Thamm M, Stark K. Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008\u20132011. Emerg Infect Dis. 2015;21:107\u201310. https:\/\/doi.org\/10.3201\/eid2101.140009.","journal-title":"Emerg Infect Dis"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-024-06449-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-024-06449-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-024-06449-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T13:05:55Z","timestamp":1725541555000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-024-06449-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6449"],"URL":"https:\/\/doi.org\/10.1186\/s13071-024-06449-5","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board (IRB) evaluation was not required because this study only involved the analysis of published data and did not involve human subject research, since only summary data and patient interviews were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Frederick J. Angulo, Veronica Purdel, Emily Colby, Andreas Pilz, Kate Halsby, Patrick H. Kelly, Gordon Brestrich, Jennifer C. Mo\u00efsi, and James H. Stark are employees of Pfizer and may hold stock or stock options. Violeta Briciu, Mihaela Lup\u0219e, and Adriana Hristea have previously received honoraria for lecturing activities from Pfizer. Violeta Briciu and Mihaela Lup\u0219e are members of the ESCMID study group for Lyme borreliosis (ESGBOR). Adriana Hristea received a research grant from Pfizer to conduct tick-borne encephalitis research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}